Price
No data yet.
Signal Score (90d)
130Aug 17Aug 17
Quote
Day Range
$41.55 – $41.78
52-Week Range
$36.44 – $42.44
Volume
$1.1K
Market Cap
$104.20M
50-Day Avg
$40.71
200-Day Avg
$39.73
Prev Close
$41.75
Open
$41.78
Valuation & Ratios
P/E Ratio
—
EPS
—
P/B Ratio
—
P/S Ratio
—
Debt/Equity
—
Current Ratio
—
Dividend Yield
—
Gross Margin
—
Returns & Efficiency
Return on Equity
—
Return on Assets
—
FCF Yield
—
EV/EBITDA
—
Social Signal Score
80
5d
81
1 mentions
—
30d
80
1 mentions
—
60d
80
1 mentions
—
90d
80
1 mentions
—
news: 1
Valuation
EVXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·6h ago·Positive
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program COPENHAGEN, Denmark, August 17, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, expands it pipeline of cancer vaccine programs with EVX-05 against the deadly brain cancer glioblastoma.
View source ↗